Gossamer Bio (GOSS) Return on Equity: 2022-2025
Historic Return on Equity for Gossamer Bio (GOSS) over the last 3 years, with Sep 2025 value amounting to 2.45%.
- Gossamer Bio's Return on Equity rose 489.00% to 2.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.45%, marking a year-over-year increase of 489.00%. This contributed to the annual value of -1.23% for FY2024, which is 358.00% up from last year.
- According to the latest figures from Q3 2025, Gossamer Bio's Return on Equity is 2.45%, which was down 54.15% from 5.34% recorded in Q2 2025.
- Over the past 5 years, Gossamer Bio's Return on Equity peaked at 27.37% during Q1 2023, and registered a low of -12.48% during Q1 2025.
- In the last 3 years, Gossamer Bio's Return on Equity had a median value of -2.44% in 2024 and averaged 0.22%.
- Per our database at Business Quant, Gossamer Bio's Return on Equity plummeted by 3,144bps in 2024 and then spiked by 857bps in 2025.
- Gossamer Bio's Return on Equity (Quarterly) stood at -6.75% in 2022, then soared by 450bps to -2.25% in 2023, then plummeted by 135bps to -3.60% in 2024, then soared by 489bps to 2.45% in 2025.
- Its last three reported values are 2.45% in Q3 2025, 5.34% for Q2 2025, and -12.48% during Q1 2025.